Skip to content

Sleep evaluation study after intake of the test food in health care workers

Sleep evaluation study after intake of the test food in health care workers - Sleep evaluation study after intake of the test food in health care workers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044323
Enrollment
80
Registered
2021-05-26
Start date
2021-05-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteer

Interventions

4-weeks intake of the test food without shift work 4-weeks intake of the placebo food without shift work 4-weeks intake of the test food with shift work 4-weeks intake of the placebo food with shift w

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor
Jeneral foundation Tohoku-seishin-hokenkai Aoba hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Persons who have obtained written consent for participation in the research. 2)Healthy men and women. 3)Persons who have undergone a physical examination within one year. 4)Persons who can take test foods, etc. and maintain rest according to the schedule instructed by researchers.

Exclusion criteria

Exclusion criteria: 1)Persons who have or had disorder in digestive, circulatory or endocrine system and who are estimated inappropriate to this study. 2)Persons who have allergy. 3)Others who are judged unsuitable as subjects by principal investigator or principal researcher (e.g., sleep apnea syndrome).

Design outcomes

Primary

MeasureTime frame
Sleep-related indices (3DSS and sleep duration, awake time, sleep score, heart rate during sleep, autonomic function)

Secondary

MeasureTime frame
(Secondary outcomes) Discomfort due to wearing masks, fatigue and stress at work, number of errors at work (Safety evaluation) General physical findings (subjective symptoms, objective findings), vital signs (weight, body temperature, blood pressure, pulse rate), frequency of adverse events

Countries

Japan

Contacts

Public ContactTsubasa Mizokami

Otsuka Pharmaceutical Co., Ltd. Saga Nutraceuticals Research Institute

Mizokami.Tsubasa@otsuka.jp0952-52-1522

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026